Showing results (41-50 of 217) with videos related to
Sort By:
Pageof 22
Breathe (Sheffield, England)|April 14, 2020
The electronic nose: emerging biomarkers in lung cancer diagnosticsWouter H van Geffen, Kevin Lamote, Adrien Costantini, et al.Pharmacoepidemiology and Drug Safety|January 14, 2026
Concordance of Lung Cancer, Melanoma, and Renal Cell Cancer Diagnosis Information Recorded in Health Care Databases in England: Analysis of Linkage Between Primary Care, Hospital Care, and Cancer Registry DataPaul D Kruithof, Patrick C Souverein, Johanna H M Driessen, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 27, 2020
Idiopathic pulmonary fibrosis: Current knowledge, future perspectives and its importance in radiation oncologyGörkem Türkkan, Yves Willems, Lizza E L Hendriks, et al.Current Oncology Reports|January 4, 2024
Measured Steps: Navigating the Path of Oligoprogressive Lung Cancer with Targeted and ImmunotherapiesMandy Jongbloed, Atulya A Khosla, Valentina Bartolomeo, et al.Cancers|November 13, 2021
A Pilot Study to Evaluate Early Predictive Value of Thorax Perfusion-CT in Advanced NSCLCFrancisco Aya, Mariana Benegas, Nuria Viñolas, et al.Journal of Clinical Medicine|August 12, 2023
PD-1/PD-L1 Inhibitors as Monotherapy in the First-Line Treatment of Advanced Non-Small Cell Lung Cancer Patients with High PD-L1 Expression: An Expert Position StatementDolores Isla, Alfredo Sánchez, Joaquín Casal, et al.Plos One|March 3, 2012
Integrin-specific mechanoresponses to compression and extension probed by cylindrical flat-ended AFM tips in lung cellsIrene Acerbi, Tomás Luque, Alícia Giménez, et al.Lung Cancer (Amsterdam, Netherlands)|April 18, 2025
Chemoradiotherapy efficacy in patients with stage III non-small cell lung cancer (NSCLC): A prognostic clinical and biomarker-based modelRianne D W Vaes, Francesco Cortiula, Shaowen Lyu, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 28, 2022
MET alterations in NSCLC-Current Perspectives and Future ChallengesJordi Remon, Lizza E L Hendriks, Giannis Mountzios, et al.Nederlands Tijdschrift Voor Geneeskunde|December 17, 2020
[Revised guideline 'Brain metastases': More treatment options]Nina A Hilkens, Roelien H Enting, Lizza E L Hendriks, et al.Pageof 22